Karolinska Development appeases shareholders with $34 million deal
This article was originally published in Scrip
Executive Summary
Sweden's Karolinska Development saw its share price jump by nearly 10% to SEK 15.00 ($2.30) by 3pm CET on 21 December, the day it announced a SEK 220 million ($33.7 million) deal to give a stake in the academic investment company's portfolio to a syndicate led by the life sciences investor Rosetta Capital.